Ascentage Pharma Group International
USD17.56
-0.14 (-0.79%)
CEO
Dajun Yang
IPO Date
2025-01-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CN
Open
$17.39
Prev. Close
$17.70
Day Low
$17.39
Day High
$17.56
52W Low
$16.36
52W High
$48.45
Market Cap
$1.63B
Volume
0.00M
| -23.6 |
| 31 Dec 2023 | FY | 86.2% | -417.0% | -1532.1% | -37.0% | 29.72 | 1.44 | -2.4 |
| 31 Dec 2022 | FY | 89.5% | -421.0% | -216.1% | -31.2% | 4.39 | 1.86 | -2.2 |
| 31 Dec 2021 | FY | 88.1% | -2803.4% | -63.4% | -26.6% | 0.88 | 5.22 | -2.2 |
| 31 Dec 2020 | FY | 84.2% | -5442.6% | -80.0% | -39.1% | 0.63 | 3.91 | -2.3 |
| 31 Dec 2019 | FY | 85.6% | -10202.7% | -166.3% | -122.9% | 0.11 | 4.50 | -1.1 |
| 31 Dec 2018 | FY | 100.0% | -5072.8% | 34.1% | -28.1% | -0.04 | 9.41 | -4.5 |
| 31 Dec 2017 | FY | 100.0% | -1872.9% | 89.9% | -20.4% | -0.04 | 5.21 | -12.3 |
| 31 Dec 2016 | FY | 96.6% | -1406.5% | 738.3% | -18.2% | -0.06 | 5.97 | -14.5 |
| -10.2 |
| 31 Dec 2024 | Q4 | 91.1% | -362.3% | -215.2% | -21.7% | 6.32 | 1.26 | -4.4 |
| 30 Jun 2024 | Q2 | 98.2% | 19.8% | 21.3% | 5.2% | 2.22 | 1.84 | 14.4 |
| 31 Dec 2023 | Q4 | 84.4% | -660.0% | -866.1% | -20.9% | 29.72 | 1.44 | -4.3 |
| 30 Jun 2023 | Q2 | 87.3% | -282.0% | -68.2% | -13.8% | 2.84 | 2.74 | -1.4 |
| 31 Dec 2022 | Q4 | 89.5% | -421.0% | -108.0% | -15.6% | 4.39 | 1.86 | -1.1 |
| 30 Jun 2022 | Q2 | 89.5% | -421.0% | -50.3% | -14.5% | 1.78 | 3.05 | -1.1 |
| 31 Dec 2021 | Q4 | 95.1% | -2617.7% | -31.7% | -13.3% | 0.88 | 5.22 | -1.1 |
| 30 Jun 2021 | Q2 | 80.0% | -3017.4% | -27.0% | -16.2% | 0.46 | 8.25 | -1.1 |